Thought Leadership & Innovation Foundation Celebrates the Launch of Autism Knowledge Gateway
10 déc. 2024 10h02 HE
|
Thought Leadership & Innovation Foundation
Thought Leadership & Innovation Foundation launches Autism Knowledge Gateway, an AI-powered platform designed to connect families, clinicians & researchers
Oncocyte to Participate in “J.P. Morgan Week” and Host Investor Meetings
09 déc. 2024 16h05 HE
|
OncoCyte Corporation
Oncocyte to Participate in “J.P. Morgan Week” and Host Investor Meetings – January 13-16, 2025, San Francisco, CA
Dr. Merit Cudkowicz, Renowned ALS Expert at Massachusetts General Hospital (MGH), Joins Klotho Neurosciences’ Scientific Advisory Board
09 déc. 2024 11h00 HE
|
Klotho Neurosciences, Inc.
Dr. Merit Cudkowicz, Renowned ALS Expert at Massachusetts General Hospital (MGH), Joins Klotho Neurosciences’ Scientific Advisory Board
Oncocyte Demonstrates Potential for Liquid Biopsy of Brain Tumors in New Study
04 déc. 2024 16h15 HE
|
OncoCyte Corporation
Oncocyte Demonstrates Potential for Liquid Biopsy of Brain Tumors in New Study
VivaVision Announces Positive Topline Results from Phase 2 Trial of VVN461 for Post-Operative Inflammation Following Cataract Surgery
04 déc. 2024 11h07 HE
|
VivaVision Biotech, Ltd.
VVN461, a non-steroidal dual JAK1/TYK2 immunomodulator, achieves primary endpoint, demonstrating statistical and clinical efficacy compared to vehicle in treating post-operative inflammation following...
Former Merck USA President Joins Klotho Neurosciences’ Board of Directors
03 déc. 2024 11h00 HE
|
Klotho Neurosciences, Inc.
Former Merck USA President Joins Klotho Neurosciences’ Board of Directors
Lipella Pharmaceuticals Announces Publication in CUREUS on Non-Steroid Treatment of Oral Lichen Planus
03 déc. 2024 08h30 HE
|
Lipella Pharmaceuticals Inc.
Lipella Pharmaceuticals Announces Publication in CUREUS on Non-Steroid Treatment of Oral Lichen Planus
Halberd Update on WatchDawg® PTSD Treatment
02 déc. 2024 08h00 HE
|
Halberd Corp.
Halberd Update on WatchDawg® PTSD Treatment
FSR Doubles Investment in Cardiac Sarcoidosis Research with $200,000 in Grants to Advance Diagnostic and Treatment Breakthroughs
27 nov. 2024 13h51 HE
|
Foundation for Sarcoidosis Research
FSR Doubles Investment in Cardiac Sarcoidosis Research with $200,000 in Grants to Advance Diagnostic and Treatment Breakthroughs
Monoclonal Antibody Collaboration and Licensing Analysis Report 2024 with Directory of 639 Deals Signed Since 2019 by Company A-Z, Deal Type and Therapeutic Target
26 nov. 2024 06h29 HE
|
Research and Markets
Dublin, Nov. 26, 2024 (GLOBE NEWSWIRE) -- The "Monoclonal Antibody Collaboration and Licensing Deals 2019-2024" report has been added to ResearchAndMarkets.com's offering. Fully revised and...